We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

87 hedge funds and large institutions have $190M invested in Antares Pharma, Inc. in 2013 Q2 according to their latest regulatory filings, with 87 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

70% less call options, than puts

Call options by funds: $650K | Put options by funds: $2.17M

Holders
87
Holders Change
+87
Holders Change %
–
% of All Funds
2.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
87
Increased
–
Reduced
–
Closed
–
Calls
$650K
Puts
$2.17M
Net Calls
-$1.52M
Net Calls Change
-$1.52M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ATRS Hedge Fund Activity: Q2 2013 in Review

87 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q2 2013, worth a combined $190M.

Buyers outnumbered sellers: 87 funds opened new ATRS positions and 0 closed out — a net gain of 87 holders — while 0 added to existing stakes and 0 trimmed.

  • 87 institutional investors held Antares Pharma, Inc. (ATRS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $190M of Antares Pharma, Inc. stock for Q2 2013.
  • 87 funds opened new Antares Pharma, Inc. positions in Q2 2013 and 0 closed out, a net change of +87 holders.

Based on aggregated 13F filings for Q2 2013.